z-logo
Premium
Respiratory and cardiovascular effects in relation to plasma levels of midazolam and diazepam.
Author(s) -
Sunzel M,
Paalzow L,
Berggren L,
Eriksson I
Publication year - 1988
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1988.tb03346.x
Subject(s) - midazolam , diazepam , blood pressure , sedative , sedation , anesthesia , respiratory system , benzodiazepine , hypnotic , medicine , blood plasma , pharmacology , receptor
1. In the present study possible relationships between cardiovascular and respiratory effects and plasma concentrations were investigated after administration of midazolam and diazepam. Eight healthy volunteers were given three injections at 20 min intervals of equipotent sedative doses of midazolam (0.05 mg kg‐1) and diazepam (0.15 mg kg‐1) in a randomized double‐blind cross‐over design. Blood pressure, blood‐gases and respiration measured nonivasively, were monitored throughout the experimental session of 160 min, and frequent blood samples were collected during the session. 2. Correlations between the blood pressure reduction, the increase of PaCO2 in blood, and plasma concentrations were found for both drugs. A maximal reduction of blood pressure and PaCO2 was produced after sedative doses of midazolam and diazepam. 3. A possible acute tolerance development towards the blood pressure reduction was found after the repeated administration of diazepam but not after the midazolam administration. 4. The plasma concentrations producing half the maximal effects after administration of midazolam was 50‐60 ng ml‐1, indicating that the influence on blood pressure and PaCO2 after drug administration is evoked at lower plasma concentrations than sedation. 5. No correlation between the respiratory effects and plasma concentrations was found for either drug.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here